Skip to content

GCRI · Labs

Future of health and biotechnology labs

Health and biotechnology research moves from bench to animal to human to population, and each step has its own ethics, safety and evidence rules. One Health links that chain to animals and environments, where many emerging pathogens begin. This lab studies how biomedical and biotech innovation is designed, contained, evaluated and translated, and what ethics committees, biosafety committees and regulators need before they let it move on.

01Register

Future of health and biotechnology labs on the record.

02The question

Future of health and biotechnology labs: how the risk develops.

Human health, One Health and biotech. The dossier below sets out how the risk develops, what is measured, where the data come from, how it is modelled and who decides.

Mechanism

Translation loses signal

Results in cells and animals often fail in people because of species differences, small samples, unblinded studies and selective publication. Weak preclinical evidence can send trials forward that expose participants without good reason.

Mechanism

Dual use and biosafety

Techniques that enhance, synthesise or edit organisms can serve harm as well as health. Containment, oversight of dual-use research and screening of synthetic DNA orders manage risks that cross laboratory walls.

Mechanism

One Health spillover

Pathogens and resistance genes move between animals, people and environments through farming, trade, water and wildlife contact. Research that studies one host alone can miss the pathway that matters.

Mechanism

Unequal evidence

Trials and datasets underrepresent many populations, regions and conditions. Treatments and diagnostic models built on that evidence can perform worse for groups that were not studied, and the gap is often invisible in pooled results.

03Geography

Environmental exposure worldwide.

Population density, daytime surface heat and haze across the world, from NASA GIBS. Each layer carries its own date.

Imephu esebenzisanayo idinga i-JavaScript; uhlu lwezendlalelo nemithombo luphansi.

Izendlalelo 3

Environmental exposure, for this page

Mayelana nalesi sendlalelo
Ubufakazi
Kulinganisiwe
Umthombo
Gridded Population of the World v4.11 (NASA SEDAC (CIESIN, Columbia University))
Umhlinzeki
NASA SEDAC (CIESIN, Columbia University)
Ilayisensi
CC BY 4.0
Inguqulo
null; isilinganiso esisekelwe ekubalweni kwabantu, akuguquki (2020)
Ukucaca
igridi elinganiselwa ku-1 km
Ukungaqiniseki
Isilinganiso esisekelwe ekubalweni kwabantu sabantu ngekhilomitha eyisikwele ngo-2020, esiboniswa njengesimo sokuchayeka; akusona isibalo sabantu abathintwe yinoma iyiphi ingozi.
Kufinyelelwe nge-
ukudluliswa kwedatha kwale sayithi, kusuka ku-gibs.earthdata.nasa.gov
Mayelana nalesi sendlalelo
Ubufakazi
Kubonwe (amafu ahlala njalo asashiya izikhala)
Umthombo
VIIRS NOAA-20 Level 3, 8-day (NASA LANCE)
Umhlinzeki
NASA LANCE
Ilayisensi
Idatha evulekile ye-NASA
Inguqulo
izinsuku ezi-8; inhlanganisela yesathelayithi yezinsuku ezi-8; amafu ahlala njalo asashiya izikhala
Okusha kakhulu ngesikhathi sokwakha
2026-09-14
Ukucaca
igridi elinganiselwa ku-1 km
Ukungaqiniseki
Izinga lokushisa kongaphezulu komhlabathi ngesathelayithi phakathi nezinsuku ezi-8 eziphela ngosuku oluboniswayo, inkomba yokuchayeka ekushiseni; akulona izinga lokushisa komoya, inkomba yokushisa noma isexwayiso sokushisa.
Kufinyelelwe nge-
ukudluliswa kwedatha kwale sayithi, kusuka ku-gibs.earthdata.nasa.gov
Mayelana nalesi sendlalelo
Ubufakazi
Kubonwe (amafu ashiya izikhala)
Umthombo
VIIRS NOAA-20 Deep Blue AOD (NASA LANCE)
Umhlinzeki
NASA LANCE
Ilayisensi
Idatha evulekile ye-NASA
Inguqulo
nsuku zonke; ukutholwa ngesathelayithi; amafu ashiya izikhala
Okusha kakhulu ngesikhathi sokwakha
2026-10-14
Ukucaca
igridi elinganiselwa ku-2 km
Ukungaqiniseki
Isilinganiso sesathelayithi senkungu, intuthu nothuli kuwo wonke umoya ngosuku oluboniswayo; inkomba yokuchayeka, hhayi i-PM2.5 ezingeni lomhlabathi, inkomba yekhwalithi yomoya noma isexwayiso sezempilo.
Kufinyelelwe nge-
ukudluliswa kwedatha kwale sayithi, kusuka ku-gibs.earthdata.nasa.gov
Mayelana nalesi sendlalelo
Ubufakazi
Kubonwe
Umthombo
VIIRS NOAA-20 corrected reflectance (NASA LANCE)
Umhlinzeki
NASA LANCE
Ilayisensi
Idatha evulekile ye-NASA
Inguqulo
daily; Satellite image
Okusha kakhulu ngesikhathi sokwakha
2026-10-14
Ukucaca
igridi elinganiselwa ku-250 m
Ukungaqiniseki
Satellite image. Satellite or model raster as the provider publishes it. Clouds, swath gaps and retrieval error leave gaps and noise; values are indicators, not measurements at a place.
Kufinyelelwe nge-
ukudluliswa kwedatha kwale sayithi, kusuka ku-gibs.earthdata.nasa.gov
Mayelana nalesi sendlalelo
Ubufakazi
Modelled (latest year GIBS publishes)
Umthombo
MODIS Terra and Aqua land cover (MCD12Q1) (NASA LP DAAC)
Umhlinzeki
NASA LP DAAC
Ilayisensi
Idatha evulekile ye-NASA
Inguqulo
yearly; Satellite classification; latest year GIBS publishes
Okusha kakhulu ngesikhathi sokwakha
2024-01-01
Ukucaca
igridi elinganiselwa ku-500 m
Ukungaqiniseki
Satellite land cover classes for the year shown, including croplands; a classification with known errors, not a farm register.
Kufinyelelwe nge-
ukudluliswa kwedatha kwale sayithi, kusuka ku-gibs.earthdata.nasa.gov
Mayelana nalesi sendlalelo
Ubufakazi
Kubonwe (amafu ashiya izikhala)
Umthombo
OMI Aura (NASA GES DISC)
Umhlinzeki
NASA GES DISC
Ilayisensi
Idatha evulekile ye-NASA
Inguqulo
nsuku zonke; ukutholwa ngesathelayithi; amafu ashiya izikhala
Okusha kakhulu ngesikhathi sokwakha
2026-10-10
Ukucaca
igridi elinganiselwa ku-2 km
Ukungaqiniseki
Satellite column of nitrogen dioxide in the lower atmosphere on the day shown, mostly from combustion; not a ground-level concentration or a health warning.
Kufinyelelwe nge-
ukudluliswa kwedatha kwale sayithi, kusuka ku-gibs.earthdata.nasa.gov

Okutholakala kwakamuva

NASA GIBS / EOSDIS · ASTER GDEM (METI, NASA) · Blue Marble (NASA) · © abanikele ku-OpenStreetMap (ODbL) · Natural Earth

Iyalayisha izithombe zakamuva ze-NASA.

Donsa ukuze unyakazise. U-Ctrl noma u-⌘ bese uskrola, ucindezele ngeminwe emibili noma izinkinobho ukuze usondeze; beka isikhombi ukuze ubone amanani aphansi kwaso; ukusetha kabusha kubuyisela esifundeni.

Environmental exposure, framed on the world.Satellite and model products as NASA publishes them, each with its own date. They are indicators, not assessments of any place.

Data: NASA GIBS · ASTER GDEM · Blue Marble · © OpenStreetMap contributors · Natural Earth · NASA EONET · NASA JPL OPERA DIST-ALERTSources and licences

  • We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Science Data and Information System (ESDIS). Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Science Data and Information System (ESDIS). Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • Center for International Earth Science Information Network (CIESIN), Columbia University. 2018. Gridded Population of the World, Version 4 (GPWv4): Population Density, Revision 11. NASA Socioeconomic Data and Applications Center (SEDAC). Licensed under CC BY 4.0. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). doi:10.7927/H49C6VHW. CC BY 4.0
  • VIIRS near-real-time products (flood, land surface temperature, snow cover, corrected reflectance), NASA LANCE; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • MODIS and VIIRS atmosphere products, NASA LANCE and LAADS DAAC; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • MODIS land products (vegetation indices, gross primary production, land cover), NASA LP DAAC and LANCE; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • OMI nitrogen dioxide (Aura) and OMPS aerosol index (Suomi NPP), NASA; distributed by the NASA GES DISC; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • ASTER GDEM is a product of METI and NASA (ASTER Global Digital Elevation Model V003, NASA LP DAAC); imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). Cite as: NASA/METI/AIST/Japan Spacesystems and U.S./Japan ASTER Science Team (2019). ASTER Global Digital Elevation Model V003. doi:10.5067/ASTER/ASTGTM.003. NASA open data
  • Kwenziwe nge-Natural Earth. Idatha yamamephu yamahhala ye-vector ne-raster ku-naturalearthdata.com. Esizindeni somphakathi
  • © OpenStreetMap contributors (ODbL), via NASA GIBS (coastlines, boundaries, roads and place names). Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). ODbL
  • Blue Marble, NASA Earth Observatory; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into hexagonal cells where shown (modified). NASA open data
  • Umongo ephaseleni nasemephini oyisicaba: amagoda olwandle, imingcele, imigwaqo namagama ezindawo avela emaleyeni ereferensi e-NASA GIBS (idatha ye-OpenStreetMap, ODbL, © abafaki be-OpenStreetMap); izithombe ze-Blue Marble njengesisekelo ongasikhetha; umhlaba we-3D nokufundwa kokuphakama okuvela enkombeni yombala wokuphakama ye-ASTER GDEM (amakilasi e-5 m kuya ku-200 m, andiswe ukuze afundeke kahle). Imingcele idwetshwe njengoba ishicilelwe futhi ayisho sikhundla ngasiphi isifunda.
  • Imicimbi eqondene nesikhathi samanje: NASA Earth Observatory Natural Event Tracker (EONET); imicimbi iyisikhombisi kuphela futhi igcina izixhumanisi zomthombo wayo wokuqala.
  • Bukhoma: NASA EONET Imicimbi iyisikhombisi, akuyizixwayiso zesiphathimandla.
  • Observed (EO): NASA JPL OPERA DIST-ALERT (contains modified Copernicus Sentinel data 2026). We acknowledge the use of imagery provided by services from NASA’s Global Imagery Browse Services (GIBS), part of NASA’s Earth Science Data and Information System (ESDIS).
  • NASA GIBS: Siyakwamukela ukusetshenziswa kwezithombe ezihlinzekwe yizinsiza ze-NASA Global Imagery Browse Services (GIBS), eziyingxenye ye-NASA Earth Science Data and Information System (ESDIS).
  • Air quality forecast, 5 days, PM2.5 (CAMS via Open-Meteo): Contains modified Copernicus Atmosphere Monitoring Service information 2026.
  • Past year, daily temperature (ERA5 via Open-Meteo): Contains modified Copernicus Climate Change Service information 2026.
  • Idatha yesimo sezulu ivela ku-Open-Meteo.com (https://open-meteo.com/), enelayisense ye-CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
  • Optional layers (14 sources in the layer list: live, forecast, observed and context) print their provider credit on the map and here when switched on; forecasts are model output and derived indices are estimates.

Izendlalelo nezinsuku

  • Population density, 2020: Population: CIESIN, Columbia University, Gridded Population of the World v4.11 (2018), NASA SEDAC, CC BY 4.0 · static
  • Land surface temperature, day, 8-day composite: VIIRS NOAA-20 Level 3, 8-day, NASA LANCE · 14 Sep 2026
  • Ukujula kokukhanya kwama-aerosol, kosuku nosuku: VIIRS NOAA-20 Deep Blue AOD, NASA LANCE · 13 Okt 2026
  • Umbala weqiniso: VIIRS NOAA-20 corrected reflectance, NASA LANCE · 13 Okt 2026
  • Land cover type (IGBP), yearly: MODIS Terra and Aqua land cover (MCD12Q1), NASA LP DAAC · 2024
  • Nitrogen dioxide, lower atmosphere column: OMI Aura, NASA GES DISC · 10 Oct 2026

04In the five domains

The health and bio labs follow biosafety rules in every experiment.

05Monitor

Testbed operations.

The screen a team would use to follow this subject: its measures, states and decisions. Names are examples and values are illustrative.

Testbed operations

Future of health and biotechnology labs · Field lab coast · Campaign 3

Sensors deployedGCRI · Labs

Sensor deployment

illustrative coastline

BuoyStationGaugeSeaBands: tidal rangeN

Sensors

S-01 tide950.2Nominal
S-04 salinity850.7Recalibrate
S-07 wave900.1Nominal

Sensor vs reference

Testbed operations: the screen’s structure, terms and states for Future of health and biotechnology labs.Example names and illustrative values; a design, not a record or a live system.
06Izinkomba

What is measured, and how well.

Each indicator carries its unit, its cadence, the kind of source behind it and the evidence label a value would carry. No values are shown: a programme supplies them under its own authority.

IndicatorUnitCadenceSource typeLabel
Trial registration before enrolmentpercent of trialsannualTrial registriesPublished statistics
Results reported within the required periodpercent of completed trialsannualRegistry results sectionsPublished statistics
ARRIVE essential items reportedpercent of itemsper studyAnimal study reporting auditsOBSERVED
Randomisation and blinding in preclinical studiespercent of studiesannualSystematic reviews of animal researchESTIMATED
Enrolment relative to the affected populationratio of enrolled share to affected share, by groupper trialTrial enrolment dataREPORTED
National dual-use research oversightpolicy in place, yes or noannualBiosafety governance mappingPublished statistics
Health research funding by diseasenational currency at constant pricesannualFunding trackersREPORTED
07Simulator

Stocks, flows, delays and a tipping threshold.

Two stocks, pressure and adaptive capacity, joined by a reinforcing growth loop, a delayed balancing response and damage when pressure outruns capacity; past the threshold the system can tip. Teaching model with stated illustrative values, not a prediction.

Controls

Growth of pressure
6.0% a year
Efficacy of capacity in reducing pressure
4.0% a year
Investment response to perceived pressure
20%
Perception delay
4.0 years
Tipping threshold of pressure
60 index
Amplification past the threshold
2.0 times
Years simulated
50 years

Readouts

Peak pressure
113 index
Capacity at the end
186 index
Years over the threshold
15.8 years
Numbers, methods and sources
YearPressureCapacityPerceived
020.050.020.0
423.344.921.2
827.242.224.0
1231.742.327.7
1636.845.532.2
2042.351.537.2
2447.960.342.6
2853.271.348.0
3257.884.353.1
3666.498.458.4
4082.7115.969.7
4497.8139.783.8
48109.1169.497.3

Izindlela

  1. System dynamics Forrester (1961), Industrial Dynamics, MIT Press; Sterman (2000), Business Dynamics
  2. Critical transitions and tipping points Scheffer and others (2009), Early-warning signals for critical transitions, Nature 461
  3. Causal loop diagram Sterman (2000), Business Dynamics, McGraw-Hill
  4. Uncertainty fan (parameter Monte Carlo) Spiegelhalter, Pearson and Short (2011), Visualising uncertainty about the future, Science 333
  5. One-at-a-time sensitivity (tornado) Saltelli and others (2008), Global Sensitivity Analysis: The Primer, Wiley

Idatha

No observed data enters this model: it runs on the teaching values set by the controls, to be replaced with a programme’s own evidence.

Stocks, flows, delays and a tipping threshold. Illustrative teaching model: it runs on the values set by the controls, not on measured data. Methods: System dynamics (Forrester (1961), Industrial Dynamics, MIT Press; Sterman (2000), Business Dynamics); Critical transitions and tipping points (Scheffer and others (2009), Early-warning signals for critical transitions, Nature 461); Causal loop diagram (Sterman (2000), Business Dynamics, McGraw-Hill).

Across the six pillars, led by Nexus Consortium

08Imithombo

Where the evidence comes from.

Named public datasets and institutional records, each with its licence class. Sources by agreement are used only under their terms and never republished.

UmthomboWhat it givesLicence class
ClinicalTrials.gov (US National Library of Medicine)Registered trials, enrolment and resultsEsizindeni somphakathi
WHO International Clinical Trials Registry PlatformRecords from primary national registriesFree, WHO terms of use
Clinical Trials Information System (European Medicines Agency)Authorised trials in the EU and their resultsPublic, EMA terms
WHO Global Observatory on Health R&DHealth research funding, trials and products by disease and regionWHO terms, CC BY-NC-SA IGO
Europe PMCBiomedical literature with open full text and links to dataFree access, licence per article
Global BioLabs (King’s College London and George Mason University)High-containment laboratories and national biosafety and biosecurity policiesFree access, attribution
G-FINDER (Policy Cures Research)Funding for research on neglected and emerging infectious diseasesFree access, terms of use
09Twin and cascade simulator

Model future of health and biotechnology labs as a system. Run the cascade.

Assembled from the Nexus Standards area profile Global and systemic risk: the hazards it names, the systems and sectors that carry the loss, the controls that dampen it and the data that observe it. Choose the components, pick an initiating hazard and step through the cascade. The Map view places the run on an example geography with open data. Every coupling weight is a stated assumption you can change. A teaching model, not a forecast, an assessment or a certification. To model a place of your own choosing, open the full System Builder.

Izingozi

  • Dam failure
  • Financial contagion
  • River flood (set off downstream)
  • Flash flood (set off downstream)
  • Mass displacement (set off downstream)
  • Widespread power outage (set off downstream)
  • Water supply shortfall (set off downstream)
  • Sovereign debt crisis (set off downstream)
  • Currency crisis (set off downstream)

Controls

  • NS-0 Umthethosisekelo nezimiso
  • NS-3 Ama-UNI amarekhodi obungozi (uhlelo lolimi, ukuqhathanisa nezinhlelo ezindala, igunya lokwabela)
  • NS-9 Ama-UNI omongo (ukufakwa, izibonelo, izibonelo zohlelo)
  • NS-10 Policies and clauses (machine-readable obligations: definition, binding, evaluation and enforcement)
  • NS-11 Ukuqinisekisa nokuqapha (ubufakazi, izifakazelo, ukuqapha ukuhambisana ngaphandle kokwethembana)
  • NS-14 Ukuhambisana nokuqhathaniswa namazinga angaphandle
  • NRS-H120 Umndeni wezingozi: Ubuthakathaka besakhiwo bezinhlelo ezixhumene (NHS-1 sys.fragility)
  • NRS-C6 Ubungozi besistimu nobulandelanayo
  • NRS-H61 Umndeni wezingozi: Ukwehluleka okulandelanayo (NHS-1 sys.cascade)
  • NRS-H62 Umndeni wezingozi: Izehlakalo ezihlangene nezezingozi eziningi (NHS-1 sys.compound)
  • NRS-H94 Umndeni wezingozi: Izehlakalo ze-inthanethi zesistimu (NHS-1 cyber.systemic-cyber)
  • NRS-H60 Umndeni wezingozi: Ukuphazamiseka kochungechunge lokuhlinzeka nokugeleza (NHS-1 sys.supply-chain)

Observation

  • INFORM Risk Index (listed for reference)
  • World Bank Open Data and World Development Indicators API (listed for reference)
  • IMF data services (WEO, IFS, FSI via SDMX) (listed for reference)
  • Direct economic loss attributed to disasters in relation to global GDP
  • Macroeconomic Dashboard

Example geography

  • Bangladesh: 134 hexagonal cells
  • Night lights tonight, outages (VIIRS Day/Night Band), NASA GIBS
  • Surface water through cloud, 30 m (OPERA DSWx-S1 radar), NASA GIBS
  • Rain rate, last half hour (IMERG), NASA GIBS
  • Surface soil moisture (SMAP), NASA GIBS
10Decisions

Who decides, and what the evidence serves.

Labs prepares evidence. The decisions below are taken by the authorities named, under their own rules, and never by the platform.

Ubani onqumayoThe questionEvidence this page serves
Research ethics committeesWhether a study with human participants may begin or continueProtocol, prior evidence, risks and benefits, consent materials, data monitoring plan
Animal welfare bodiesWhether animal use is justified, minimised and refinedHarm-benefit assessment, sample size rationale, alternatives considered under the Three Rs
Institutional biosafety committees and national biosecurity authoritiesWhether work at a given containment level or with dual-use potential may proceedRisk assessment, containment, training, oversight and screening arrangements
Medicines regulatorsWhether a product’s evidence supports authorisation for the intended populationTrial results, representation of the intended population, preclinical package

Outputs this topic produces

  • Preclinical protocols built to ARRIVE, with randomisation, blinding and sample size planned
  • Trial protocols to SPIRIT and reports to CONSORT, registered before enrolment
  • Biosafety and dual-use risk assessments filed with the institutional committee
  • One Health study designs that sample people, animals and environment together
11Sector signature

The sector signature of future of health and biotechnology labs.

The sectors future of health and biotechnology labs touches and how strongly they depend on each other: what a study has to observe and model together.

Select corners · hover lines6 / 15 relations

Signature

Health and its partners

Health gives workforce for operations to infrastructure (0.3), farm labour to food (0.3) and utility workforce to water (0.2).

W · E · I · F · H · B

Imikhakha
4 kwangu-6
Ubudlelwano
6 kwangu-15
Ukuhlanganiswa
0.42 ingxenye yesamba

Strongest relations in play

  • Water → Food · irrigation0.8
  • Food → Health · nutrition0.7
  • Infrastructure → Water · pipes, dams and treatment works0.6
  • Water → Health · drinking water and sanitation0.7
Teaching values for a typical city-region, not measurements for any place. Coupling is the summed strength of the relations in play, as a share of all fifteen.
12Core questions

What experts ask in health and biology.

  • How do environmental changes, such as heat, flooding or land use, change disease risk?
  • Where do human, animal and environmental health meet, and where does surveillance miss signals?
  • Which interventions reduce transmission or harm, and how robust is the evidence?
  • How can biological research and biotechnology be pursued safely and securely?
  • How do health systems cope when other systems, such as power or water, fail?
13Methods and evidence

How future of health and biotechnology labs is modelled, measured and tested.

The model, its assumptions, its data and its uncertainty, in the form a scientist or engineer would check. Structures follow published methods. The values drawn are illustrative, not findings.

Model, equations and assumptions

The model structure used for future of health and biotechnology labs, the assumptions it makes and how each is tested.

Risk of element iRi = f(Hi, Ei, Vi, Ci)hazard, exposure, vulnerability and coping capacity
Expected annual lossEAL = ∑k pk · Lkover events k with annual probability pk
Coupled systemsxt+1 = A xt + B ut + εtA carries the couplings, u the shock, ε the error
AssumptionWhy it is madeHow it is tested
Hazard and exposure are independent within an eventKeeps the loss integral tractableCompare with a copula fit on joint records
Couplings are linear near the operating pointLets shocks propagate through APerturb beyond the linear range and compare
Vulnerability curves transfer between placesLocal curves are rarely availableValidate against observed losses where they exist
Inputs
versioned datasets with provenance
Okuphumayo
distributions, never single numbers
Code
released with the model card and tests
Reproduction
same data, code, environment and seed
Standard risk and state-space formulations; the assumptions listed are typical of the method, stated for review, not results.
FAIR guiding principles · GO FAIR and FORCE11W3C PROV · World Wide Web ConsortiumGuidance on consistent treatment of uncertainties · IPCCCEOS Analysis Ready Data · Committee on Earth Observation Satellites
14Mechanisms and drivers

Mechanisms that link health to other systems.

The One Health approach recognises that human, animal and ecosystem health are interdependent. Many emerging infectious diseases originate in animals, and spillover risk is shaped by land-use change, wildlife trade, livestock systems and climate. Antimicrobial resistance develops wherever antimicrobials are used, in human medicine, agriculture and the environment, and spreads through water, food and travel.

Heat is a direct health hazard, especially for older people, outdoor workers and those with chronic illness, and it interacts with air pollution and power outages. Flooding and drought affect water quality and sanitation, raising the risk of waterborne disease. Health facilities depend on electricity, water, supply chains and staff who can reach work.

Biotechnology brings new tools for diagnosis, vaccines and treatment, and new risks if techniques are misused or containment fails. Biosafety concerns accidental harm; biosecurity concerns deliberate misuse.

15Methods and data

Methods, data and their limits.

  1. 01

    Epidemiological studies

    Cohort, case-control and time-series designs relating exposures to outcomes. Confounding and reporting gaps limit causal claims.

  2. 02

    Integrated surveillance

    Linking human, animal and environmental data, including wastewater monitoring. Coverage is uneven and data sharing is often restricted.

  3. 03

    Laboratory work

    Research under biosafety rules and containment levels set by competent authorities. Laboratory results require field confirmation.

  4. 04

    Modelling

    Transmission and exposure models using probability and statistics. Models depend on uncertain parameters and behaviour.

No Labs activity involving pathogens, human participants or animals proceeds without approval from the competent ethics and biosafety bodies for that study and site.

17Where this page’s references

Where this page’s references lead.

The bodies and documents this page is read against. Status and editions change; each link goes to the issuing body.

18Imibuzo

Questions and answers.

What is One Health?
An approach that treats the health of people, animals and ecosystems as linked, promoted by the Quadripartite of FAO, UNEP, WHO and WOAH. In research it means designs that study more than one host and their shared environment.
What is dual-use research of concern?
Life sciences research that could reasonably be misapplied to cause significant harm. Institutions and national authorities identify and oversee it under their own policies.
Why do treatments that work in animals fail in people?
Species differ, preclinical studies are often small and unblinded, and positive animal results are published more often than negative ones. Better design and reporting reduce the gap but do not remove it.
Does Labs operate high-containment laboratories?
No such facility is listed. Any laboratory work is designed to take place in facilities licensed for the relevant containment level, under their own authorities.
Is clinical research part of these labs?
Only under full ethics approval and the regulations that apply in each jurisdiction. The labs focus mainly on population, environmental and systems questions.
How is dual-use research handled?
Proposals are designed to be screened for misuse potential, and work that raises serious biosecurity concerns is not taken on.
ImibikoNikela

Nikela ngobufakazi kusuka kuleli khasi.

Reports is the Consortium’s quarterly publication. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work.

GCRIAmalabhorethriUbufakazi be-LabsIzindlela Nezobuchwepheshe
Amalabhorethri

Bring a method, a dataset or a question.

Information and enquiries are open today. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.